Iron protein acetyl aspartate
Small moleculeexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Nov 29, 2016 (NCT03523455)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- IronSupplementation
Iron supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03524651 | Phase 4 | May 2, 2018 | General Hospital of Chalkida, Unipharm, Inc., University of Athens |
| NCT03523455 | N/A | Nov 29, 2016 | ChemiNutra, University of Mary Hardin-Baylor |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ChemiNutra | For profit | 1 | 0 | 1 | 2016 |
| General Hospital of Chalkida | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Unipharm, Inc. | For profit | 1 | 1 | 1 | 2018 |
| University of Athens | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Mary Hardin-Baylor | Academic/Hospital | 1 | 1 | 1 | 2016 |
5 organizations
Page 1 / 1